Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

PACB

+ Watchlist+ Portfolio

Pacific Biosciences of California, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$1.82
52-Week Range
$1.07 – $3.44
Market Cap
$571.39M
P/E (TTM)
—
EPS (TTM)
-0.42
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-44.07%
Gross Margin
27.67%
Operating Margin
-332.99%
Profit Margin
-81.31%
Current Ratio
4.62
Debt/Equity
—
Total Debt
$708.37M
Free Cash Flow
$44.06M
Revenue Growth
5.50%
Earnings Growth
—
Enterprise Value
$1.08B

Market Snapshot

About

Pacific Biosciences develops and manufactures sequencing systems for genetic analysis, specializing in long-read sequencing technology. The company produces the Sequel and Revio systems, which can read much longer DNA fragments than traditional short-read sequencing, enabling better genome assembly and detection of structural variants. Its technology is used in research, clinical diagnostics, and agricultural genomics.